Schedule 13D ownership disclosure
Tenaya Therapeutics Inc
Security class unavailable · CUSIP: 87990A106
Event date: 2022-11-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-22-006912
- Form type
- SC 13D
- Filer
- Casdin Capital, LLC
- CIK
- CIK 1534261
- Filed
- Nov 28, 2022
- Reporting period
- Nov 17, 2022
- Description
- Schedule 13D beneficial ownership